MediPharm Labs Shares Trading in United States on OTCQB
Perth, Jan 8, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (
ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is pleased to attach a copy of a news release announcing that the common shares of MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (MLCPF:OTCMKTS) have commenced trading on the OTCQB Market (the "OTCQB"), a trading platform in the United States that is operated by the OTC Markets Group in New York. MediPharm Labs is trading on the OTCQB under the symbol "MLCPF" and continues to trade on the TSX Venture Exchange ("TSX-V") under the symbol "LABS".
MMJ owns approximately 4.4 million shares for a 4.5% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. MediPharm Labs' most recent closing share price on the TSX-V was CAD$1.98, more than 2.3 times MMJ's cost per share.
To view the news release, please visit:
http://abnnewswire.net/lnk/L1D2K2C8
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
